Technology | Magnetic Resonance Imaging (MRI) | December 11, 2017

Toshiba Vantage Galan 3T XGO Edition MRI Features New Advanced Gradient

Saturn X Gradient provides 30 percent increase in SNR during neuro MR exams; system also offers enhanced cardiac capabilities

Toshiba Vantage Galan 3T XGO Edition MRI Features New Advanced Gradient

December 11, 2017 — Toshiba Medical, a Canon Group company, demonstrated the Vantage Galan 3T XGO Edition magnetic resonance imaging (MRI) system with the all-new Saturn X Gradient, pending U.S. Food and Drug Administration (FDA) 510(k) clearance, at the 2017 Radiological Society of North America (RSNA) annual meeting, Nov. 26 – Dec. 1 in Chicago. The Saturn X Gradient features an advanced strength of 45 mT/m (milliTesla per meter) to offer healthcare providers fast, higher-resolution imaging, while continuing to deliver streamlined workflow and patient comfort.

The Saturn X Gradient on the Galan 3T XGO Edition comes with Toshiba Medical’s PUREGradient digital technology, which can provide up to 30 percent improved signal-to-noise ratio (SNR) for brain diffusion weighted imaging (DWI), resulting in even higher-resolution neuro images than previously offered. The Galan 3T XGO Edition offers the ability to conduct quick, comfortable and high-quality neuro imaging exams, and allows for faster sampling and higher-resolution images thanks to PURERF and Saturn technologies. This, combined with the ability to stack protocol sequences, results in quick neuro exams, enabling healthcare providers to produce higher resolution images for myriad neuro exams in under five minutes. The Galan 3T XGO Edition also offers Multiband SPEEDER technology, which allows for multiple slices to be acquired at the same time, reducing diffusion weighted imaging scan times by up to two times.

Beyond its neuro capabilities, the Galan 3T XGO Edition also offers enhanced cardiac imaging capabilities, including T1 mapping that utilizes MOdified Look-Locker Inversion recovery (MOLLI) sequence and allows providers to acquire a more quantitative characterization of myocardial tissue within a single breath hold. Additionally, Phase Sensitive Inversion Recovery (PSIR) in the heart provides improved contrast in late-enhanced imaging and eliminates the need for inversion time (TI) calibration scan, allowing cardiac exams to be completed with fewer breath holds and greater patient comfort.

For more information: www.medical.toshiba.com

 


Related Content

News | Cardiac Imaging

Nov. 30, 2025 — KA Imaging Technology has announced that its Reveal 35C detector with SpectralDR technology will be ...

Home December 01, 2025
Home
News | Cardiac Imaging

Nov. 13, 2025 — Esaote has announced a new strategic partnership with Schiller Americas. This collaboration strengthens ...

Home November 14, 2025
Home
News | Cardiac Imaging

Oct. 1, 2025 – Intelerad has announced the next generation of InteleHeart, a reimagined, all-in-one cardiology platform ...

Home October 02, 2025
Home
News | Cardiac Imaging

Sept. 22, 2025 — Heartflow, Inc. has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Next Gen ...

Home September 23, 2025
Home
News | Cardiac Imaging

Aug. 13, 2025 — BioCardia, Inc., a provider of cellular and cell-derived therapeutics for treating cardiovascular and ...

Home August 15, 2025
Home
News | Cardiac Imaging

July 28, 2025 — Frost & Sullivan has named Siemens Healthineers the 2025 North America Company of the Year in the ...

Home July 28, 2025
Home
News | Cardiac Imaging

July 25, 2025 — Data in recent staffing surveys from the American Society of Radiologic Technologists show that vacancy ...

Home July 25, 2025
Home
News | Cardiac Imaging

July 17, 2025— Heartflow, Inc. recently announced new data for its AI-enabled Heartflow Plaque Analysis, including final ...

Home July 17, 2025
Home
News | Cardiac Imaging

July 15, 2025 – Cleerly has announced that EviCore, a leading radiology benefit manager providing coverage guidelines to ...

Home July 16, 2025
Home
News | Cardiac Imaging

July 11, 2025 — Heartflow, Inc. has announced that its Heartflow Plaque Analysis will be included in updated cardiac ...

Home July 15, 2025
Home
Subscribe Now